Literature DB >> 15073968

Assessing the validity of diagnostic information in administrative health care utilization data: experience in Saskatchewan.

N S Rawson1, C D'Arcy.   

Abstract

Administrative health care utilization databases have been promoted as resources for pharmacoepidemiologic research for several years, but the validity of the diagnostic data in many systems has not been thoroughly investigated. This work outlines issues in assessing the validity of diagnostic information from a broad perspective, using results from the datafiles of the province of Saskatchewan to illustrate them and, where possible, contrasting them with findings from other databases. An evaluation of the validity of health care utilization data should be more than a simple check of coding and data entry errors. Comparisons of data records with information external to the computer system, an examination of the internal consistency of the data (especially in systems consisting of several data sources) and, where practicable, an assessment of the cohesiveness of the data within the context of current medical knowledge should be performed on a broad range of diagnoses and procedures. Careful consideration should also be given to the generalizability of results from the database. Summaries of such evaluations for all databases used for population-health research purposes should be widely disseminated. We caution researchers to continue to seek ways to validate their results in each use of these databases. Copyright 1998 John Wiley & Sons, Ltd.

Year:  1998        PMID: 15073968     DOI: 10.1002/(SICI)1099-1557(199811/12)7:6<389::AID-PDS380>3.0.CO;2-S

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  20 in total

1.  Validity of The Health Improvement Network (THIN) for the study of psoriasis.

Authors:  N M Seminara; K Abuabara; D B Shin; S M Langan; S E Kimmel; D Margolis; A B Troxel; J M Gelfand
Journal:  Br J Dermatol       Date:  2011-02-03       Impact factor: 9.302

2.  Deriving comorbidities from medical records using natural language processing.

Authors:  Hojjat Salmasian; Daniel E Freedberg; Carol Friedman
Journal:  J Am Med Inform Assoc       Date:  2013-10-31       Impact factor: 4.497

Review 3.  Healthcare Databases for Drug Safety Research: Data Validity Assessment Remains Crucial.

Authors:  Nigel S B Rawson; Carl D'Arcy
Journal:  Drug Saf       Date:  2018-09       Impact factor: 5.606

4.  Psoriasis and cardiovascular risk: strength in numbers.

Authors:  Joel M Gelfand; Rahat S Azfar; Nehal N Mehta
Journal:  J Invest Dermatol       Date:  2010-04       Impact factor: 8.551

5.  Concordance on the recording of cancer in the Saskatchewan Cancer Agency Registry, hospital charts and death registrations.

Authors:  N S Rawson; D L Robson
Journal:  Can J Public Health       Date:  2000 Sep-Oct

6.  Performance of comorbidity measures for predicting outcomes in population-based osteoporosis cohorts.

Authors:  L M Lix; J Quail; G Teare; B Acan
Journal:  Osteoporos Int       Date:  2011-01-11       Impact factor: 4.507

7.  Medicaid expenditures for children with autistic spectrum disorders: 1994 to 1999.

Authors:  David S Mandell; Jun Cao; Richard Ittenbach; Jennifer Pinto-Martin
Journal:  J Autism Dev Disord       Date:  2006-05

8.  The sex factor: epidemiology and management of chronic obstructive pulmonary disease in British Columbia.

Authors:  Pat G Camp; Munaza Chaudhry; Howard Platt; Michael Roch; Jeremy Road; Donald Sin; Robert D Levy
Journal:  Can Respir J       Date:  2008 Nov-Dec       Impact factor: 2.409

9.  Real life anticoagulation treatment of patients with atrial fibrillation in Germany: extent and causes of anticoagulant under-use.

Authors:  Thomas Wilke; Antje Groth; Matthias Pfannkuche; Oliver Harks; Andreas Fuchs; Ulf Maywald; Bernd Krabbe
Journal:  J Thromb Thrombolysis       Date:  2015-07       Impact factor: 2.300

10.  Population-based patterns of prescription androgen use, 1976-2008.

Authors:  Susan A Hall; Gayatri Ranganathan; Liane J Tinsley; Jennifer L Lund; Varant Kupelian; Gary A Wittert; Philip W Kantoff; Alvaro Morales; Andre B Araujo
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-02-07       Impact factor: 2.890

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.